Managers / Q4 2023 · view latest →
Price Jennifer C.
CIK 0001930102
Summary
Price Jennifer C. reported $150M in U.S.-listed holdings across 50 positions for Q4 2023.
Its largest position, Bunge Limited, represents 13.4% of the portfolio.
Compared with Q3 2023, the fund opened 3 new positions and exited 3.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 61.8% · $93M
- Other · 27.3% · $41M
- MLP · 6.6% · $10M
- ADR · 3.8% · $6M
- Royalty Trst · 0.4% · $602,279
Quarter-over-Quarter Changes full breakdown →
vs Q3 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| CDLRCADELER A S | NEW | +289.7K | 289.7K | +$5M | $5M |
| STNGSCORPIO TANKERS INC | NEW | +33.0K | 33.0K | +$2M | $2M |
| Mural Oncology PLC | NEW | +11.5K | 11.5K | +$68,080 | $68,080 |
| DHTDHT HOLDINGS INC | SOLD OUT | −336.3K | 0 | −$3M | $0 |
| ENETI INC | SOLD OUT | −340.0K | 0 | −$3M | $0 |
| PAGPPlains GP Holdings LP | SOLD OUT | −2 | 0 | −$32 | $0 |
| TRCTejon Ranch Co. | TRIMMED | −186.4K | 64.1K | −$3M | $1M |
| Laboratory Corporation of America | TRIMMED | −33.2K | 25.0K | −$6M | $6M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2023
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2024 | $75M | 31 | Feb 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $90M | 30 | Nov 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $86M | 37 | Aug 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $106M | 40 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $150M | 50 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $173M | 50 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $291M | 72 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $314M | 78 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $418M | 88 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $485M | 112 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $585M | 125 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- MFP INVESTORS LLC028-05359
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.